• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem High Test Results (2457)
Patient Problems Vomiting (2144); Dizziness (2194); Ischemia Stroke (4418)
Event Date 04/18/2022
Event Type  Injury  
Event Description
On 10-jun-2022, we received an allegation of questionable inr results for one patient tested with a coaguchek xs serial number (b)(4) compared to a laboratory stago max compact analyzer with neoplastin reagent.Reportedly the patient had a blood clot and received treatment on (b)(6) 2022.There were two test strip lot numbers reported, but it is unknown which results were generated from each lot number.Test strip lot number 54974524 had an expiration date of 31-jan-2023.Test strip lot number 57260821 had an expiration date of 31-may-2023.On (b)(6) 2022, the patient's meter result was 3.2 inr.On (b)(6) 2022, the patient allegedly felt dizzy and vomited and went to the emergency room.Reportedly the patient's inr result at the hospital was 2.9 inr.Based on the laboratory inr result, allegedly the patient's warfarin dosage was changed.It was reported the patient had a computerized axial tomography (cat) scan and a magnetic resonance imaging (mri) scan to determine if he had a blood clot.Allegedly the patient's doctor stated the blood clot was on the way to the brain but the specific location was unknown.Reportedly the patient was provided "fluids" but the specific treatment was unknown.It was reported the blood clot dissolved.Allegedly the patient was in the hospital overnight for observation and discharged on (b)(6) 2022.Prior to the event, the patient¿s dosage was determined from the meter inr results.Following the event, it was reported the patient¿s dosage was determined from the laboratory inr results.After the event, the patient had the following meter-to-lab comparison results: (b)(6).The patient's testing frequency is weekly.The patient's current condition was reportedly normal.
 
Manufacturer Narrative
The test strips and meter were requested for an investigation, however, the test strips are not available for return.Replacement product was sent.The product has not been received at this time.If the product is returned in the future, a follow up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." occupation is patient's wife/consumer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key14956581
MDR Text Key295491323
Report Number1823260-2022-02000
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 07/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number04625374160
Device Lot Number54974524, 57260821
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/10/2022
Initial Date FDA Received07/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
"DILTIZEM HCL"; ASPIRIN; ATORVASTATIN; FUROSEMIDE; LOSARTAN POTASSIUM; METOPROLOL; WARFARIN
Patient Outcome(s) Hospitalization; Other;
Patient Age62 YR
Patient SexMale
Patient Weight108 KG
-
-